Grail (NASDAQ: GRAL)
$23.18
(1.9%)
$0.43
Price as of April 11, 2025, 3:58 p.m. ET
GRAL
Key Data Points
Current Price
$23.18
Daily Change
(1.9%) $0.43
Day's Range
$22.32 - $23.38
Previous Close
$23.26
Open
$22.91
Beta
2.36
Volume
1,026,629
Average Volume
1,533,293
Sector
Market Cap
$788M
Market Cap / Employee
$788MM
52wk Range
$12.33 - $63.99
Revenue
$126M
Gross Margin
-62.12%
Dividend Yield
N/A
EPS
-$64.76
CAPs Rating
-
Industry
Biotechnology
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Grail Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Grail Company Info
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
News & Analysis
No articles found.
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q2 2024 | Q3 2024 | Q4 2024 |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.